Compare BridgeBio Pharma Inc (BBIO) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Ross Stores, Inc. — how do they compare? BridgeBio Pharma Inc trades at $83.41 (market cap $16.36B), while Ross Stores, Inc. trades at $251.3 (market cap $80.78B). The key difference: Ross Stores, Inc. is far larger — about 4.9× BridgeBio Pharma Inc's market cap, and Ross Stores, Inc. pays a 0.71% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | ROST | |
|---|---|---|
Market Cap | $16.36B | $80.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $90.17 | $255.23 |
52-Week Low | $47.29 | $144.67 |
Enterprise Value | $18.14B | $81.37B |
Dividend Yield | — | 0.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
